加载中
NASDAQFinancial ServicesAsset Management - Cryptocurrency
最新数据
US$3.40
+US$0.035 · +1.04%
Hyperion DeFi, Inc. is a U.S. publicly listed company that is building a long-term strategic treasury of HYPE, the native token of the Hyperliquid blockchain. The company's primary objective is to provide shareholders with streamlined access to the Hyperliquid ecosystem. Shareholders gain compounding exposure to HYPE through the token's native staking yield and additional revenues from its on-chain utility. The company also continues the development of its proprietary Optejet User Filled Device for ophthalmic applications, reflecting its transformation from its prior focus on ophthalmic technology.
前收盘价
US$3.40
+US$0.035 · +1.04%
盘中时间采用ET。市场数据可能有所延迟。
Hyperion DeFi, Inc. is a U.S. publicly listed company that is building a long-term strategic treasury of HYPE, the native token of the Hyperliquid blockchain. The company's primary objective is to provide shareholders with streamlined access to the Hyperliquid ecosystem. Shareholders gain compounding exposure to HYPE through the token's native staking yield and additional revenues from its on-chain utility. The company also continues the development of its proprietary Optejet User Filled Device for ophthalmic applications, reflecting its transformation from its prior focus on ophthalmic technology.
日内区间
当前US$3.40
52周区间
当前US$3.40
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
51
合理估值
情绪
46
多空交织
风险
82
极高风险
动量
20
强势下行
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Hyperion DeFi, Inc. is a U.S. publicly listed company that is building a long-term strategic treasury of HYPE, the native token of the Hyperliquid blockchain. The company's primary objective is to provide shareholders with streamlined access to the Hyperliquid ecosystem. Shareholders gain compounding exposure to HYPE through the token's native staking yield and additional revenues from its on-chain utility. The company also continues the development of its proprietary Optejet User Filled Device for ophthalmic applications, reflecting its transformation from its prior focus on ophthalmic technology.
日内区间
当前US$3.40
52周区间
当前US$3.40
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 81.35万 USD | 5.73万 USD | 3787 USD | — | 1400万 USD |
| 销货成本 | 30.33万 USD | 392.72万 USD | 1.6万 USD | — | 160万 USD |
| 毛利 | 51.02万 USD | −386.99万 USD | −1.22万 USD | — | 1240万 USD |
| 研究与开发 | 191.04万 USD | 1446.27万 USD | 1297.58万 USD | 1337.87万 USD | 1485.09万 USD |
| 销售、一般及管理费用 | 1717.57万 USD | 1433.31万 USD | 1241.84万 USD | 1452.69万 USD | 1056.97万 USD |
| 营业费用 | 1949.15万 USD | 4486.83万 USD | 2539.42万 USD | 2691.15万 USD | 2542.05万 USD |
| 利息收入 | 24万 USD | 25.4万 USD | 69.36万 USD | 8.33万 USD | 2516 USD |
| 利息支出 | 155.78万 USD | 248.44万 USD | 237.19万 USD | 138.01万 USD | 38.78万 USD |
| 折旧和摊销 | — | 112.84万 USD | 78.32万 USD | 30.74万 USD | 22.16万 USD |
| 营业利润 | −1898.13万 USD | −4873.82万 USD | −2540.64万 USD | −2691.15万 USD | −1302.05万 USD |
| 净利润 | −4531.44万 USD | −4981.84万 USD | −2726.11万 USD | −2801.12万 USD | −1277.84万 USD |
公司数据更新于 2026年10月11日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$9.82
上涨空间 188.82%评级样本有限，仅3项
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2025年2月3日 | 1:80 | — | — |
已生效 2025年2月3日
1:80
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
